ADELMIDROL FOR USE IN DISEASES CHARACTERIZED BY INSUFFICIENT AGONISM OF PPAR-GAMMA… Grant AU-2021202182-B2 Australia 25 May 2023
ADELMIDROL FOR USE IN THE TREATMENT OF DISEASES CHARACTERIZED BY AN ABNORMAL FIBROSIS OF… Application EP-3827819-A1 European Patent Office 02 Jun 2021
ADELMIDROL FOR USE IN THE TREATMENT OF DISEASES SENSITIVE TO THE SPECIFIC AGONISM OF THE… Application EP-3162365-A3 European Patent Office 12 Jul 2017